A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

NCT05037760 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Elritercept
DRUG: Ruxolitinib

Sponsor

Takeda